Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass

Lancet. 1990 Mar 31;335(8692):799-800. doi: 10.1016/0140-6736(90)90922-r.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Aprotinin / therapeutic use*
  • Cardiopulmonary Bypass / adverse effects*
  • Drug Evaluation
  • Female
  • Hemostasis, Surgical / methods*
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Time Factors

Substances

  • Aprotinin